Drug Shortage Report for ALTACE HCT

Last updated on 2020-05-13 History
Report ID 101030
Drug Identification Number 02283182
Brand name ALTACE HCT
Common or Proper name ALTACE HCT
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE RAMIPRIL
Strength(s) 25.0MG 10.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-12-05
Estimated end date
Actual end date 2020-05-12
Shortage status Resolved
Updated date 2020-05-13
Company comments artwork related
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-05-13 French Compare
v15 2020-05-13 English Compare
v14 2020-05-07 French Compare
v13 2020-05-07 English Compare
v12 2020-04-09 French Compare
v11 2020-04-09 English Compare
v10 2020-03-05 French Compare
v9 2020-03-05 English Compare
v8 2020-02-28 French Compare
v7 2020-02-28 English Compare
v6 2020-02-14 French Compare
v5 2020-02-14 English Compare
v4 2020-01-09 French Compare
v3 2020-01-09 English Compare
v2 2019-12-11 French Compare
v1 2019-12-11 English Compare